[Chemo-endocrine-immuno therapy with adriamycin, tamoxifen and OK-432 for advanced breast cancer].
D001688:Biological Products / Q000008:administration & dosage*; D001943:Breast Neoplasms / Q000188:drug therapy*; D002285:Carcinoma, Intraductal, Noninfiltrating / Q000188:drug therapy; D004317:Doxorubicin / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D010844:Picibanil / Q000008:administration & dosage*; D013629:Tamoxifen / Q000008:administration & dosage*
D001688:Biological Products; D013629:Tamoxifen; D010844:Picibanil; D004317:Doxorubicin